THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,052 | -71.6% | 20,400 | -65.9% | 0.00% | -100.0% |
| Q2 2023 | $619,054 | +96.5% | 59,812 | +299.0% | 0.00% | -50.0% |
| Q2 2020 | $315,000 | +71.2% | 14,990 | +83.7% | 0.00% | +100.0% |
| Q1 2019 | $184,000 | +76.9% | 8,160 | +100.0% | 0.00% | 0.0% |
| Q4 2018 | $104,000 | -99.2% | 4,080 | -99.0% | 0.00% | -98.8% |
| Q4 2016 | $13,035,000 | +355.0% | 408,880 | +417.1% | 0.09% | +330.0% |
| Q3 2016 | $2,865,000 | +432.5% | 79,068 | +233.5% | 0.02% | +300.0% |
| Q2 2016 | $538,000 | – | 23,706 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |